Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Identifying novel microbially-produced factors that reduce of the virulence of Pseudomonas aeruginosa using the model organism Caenorhabditis elegans
FY 2019-20
Summary
"The discovery of the antibiotic penicillin in 1942 transformed the way medicine could be practiced by drastically reducing the risk of infection. This allowed for invasive surgeries to be performed such as C-section births and implantation of life-saving medical devices. However, pathogenic bacteria that cause these infections are constantly changing and gaining ways to evade the action of antibiotics. In recent years, pathogenic bacteria that cannot be destroyed by any known antibiotic have emerged, therefore, new antibiotics must be discovered. In my proposed research, I will be using the animal model C. elegans to search through a large collection of compounds with potential activity against antibiotic-resistant bacteria. C. elegans is a microscopic worm that can be infected and killed by many pathogens that cause infection in humans. C. elegans is particularly beneficial to use for this project because they grow and die quicker than other animals used to study infection, facilitating the ability to efficiently identify potential anti-infectives within large compound collections. In addition, my project will also investigate the role of the human microbiome in altering the susceptibility of acquiring an infection. The microbiome is the collection of beneficial bacteria that live on and in the human body, and are involved in maintaining human health in a number of ways, such as preventing infection by pathogenic bacteria. I will be exposing C. elegans to a number of different bacteria from the human microbiome to identify bacterial isolates that can protect C. elegans when infected with antibiotic-resistant pathogens. This project will aid in the discovery of new antibiotics, and increase our understanding of how the microbiome influences susceptibility to infection. "
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428789
Name
DiBernardo Mercedes
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying novel microbially-produced factors that reduce of the virulence of Pseudomonas aeruginosa using the model organism Caenorhabditis elegans
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antimicrobial Discovery; Caenorhabditis Elegans; Infectious Disease; Microbiome; Pseudomonas Aeruginosa
Abstract
"The discovery of the antibiotic penicillin in 1942 transformed the way medicine could be practiced by drastically reducing the risk of infection. This allowed for invasive surgeries to be performed such as C-section births and implantation of life-saving medical devices. However, pathogenic bacteria that cause these infections are constantly changing and gaining ways to evade the action of antibiotics. In recent years, pathogenic bacteria that cannot be destroyed by any known antibiotic have emerged, therefore, new antibiotics must be discovered. In my proposed research, I will be using the animal model <em>C. elegans</em> to search through a large collection of compounds with potential activity against antibiotic-resistant bacteria. <em>C. elegans</em> is a microscopic worm that can be infected and killed by many pathogens that cause infection in humans. <em>C. elegans</em> is particularly beneficial to use for this project because they grow and die quicker than other animals used to study infection, facilitating the ability to efficiently identify potential anti-infectives within large compound collections. In addition, my project will also investigate the role of the human microbiome in altering the susceptibility of acquiring an infection. The microbiome is the collection of beneficial bacteria that live on and in the human body, and are involved in maintaining human health in a number of ways, such as preventing infection by pathogenic bacteria. I will be exposing <em>C. elegans to</em> a number of different bacteria from the human microbiome to identify bacterial isolates that can protect <em>C. elegans</em> when infected with antibiotic-resistant pathogens. This project will aid in the discovery of new antibiotics, and increase our understanding of how the microbiome influences susceptibility to infection. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
DiBernardo, Mercedes
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~